Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A German-Austrian, Single-Arm, Open-Label, Prospective, Noninterventional, Observational Study

Patrick H. Biggar,Josef Kovarik,Renate Klauser-Braun,Graf H,Hans-Walter Müller,András Veres,Susanne Seidinger,Markus Ketteler

Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A German-Austrian, Single-Arm, Open-Label, Prospective, Noninterventional, Observational Study

2014

Patrick H. Biggar
Josef Kovarik
Renate Klauser-Braun
Graf H
Hans-Walter Müller
András Veres
Susanne Seidinger
Markus Ketteler

Background: Safety and efficacy of paricalcitol in hemodialysis patients with secondary hyperparathyroidism (sHPT) was investigated under routine clinical practic

Keywords:

Intensive care medicine
Dialysis
Paricalcitol
Medicine
Hemodialysis
Hyperphosphatemia
Observational study
Secondary hyperparathyroidism
Diabetes mellitus
open label
Internal medicine
Endocrinology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations